Chat IA
Loading data for TRUMY — first visit, this takes a few seconds.

Terumo Corporation

TRUMY · OTC Markets OTCPK · USD

14.67 -0.31 (-2.07%)

Al cierre: Sep 11, 2026, 3:30 PM

Volumen
11.8K

Terumo Corporation (TRUMY): cotización, análisis y datos

Valor intrínseco

Cargando valor intrínseco…

Pronóstico del analista

Previsiones bursátiles →

Previsión de analistas no disponible

Objetivo a 12 meses · n/a analistas

Consenso de analistas: n/a

Intervalo:1D
Cargando velas y señales…

Desempeño financiero

Ver finanzas →

Cargando...

Últimos resultados

ReportadoVs. estimaciónCambio interanual
Ingresosn/an/a
EPSn/an/a

Próximos resultados

durante el horario de mercado.

Estimar · Actualizar →

Ver detalles de resultados →

Métricas

Precio de compra
14.69
Beneficio neto (TTM)
164B
0.23
0.6
24.43
n/a
P/B (TTM)
2.15
P/S (TTM)
0.02
Fecha de resultados
Nov 11, 2026
Precio de venta
14.72
Volumen
11,844
Volumen medio (20D)
106,359
Abierto
14.75
Anterior Cerrar
14.98
Rango del día
14.67 - 14.76
Rango de 52 semanas
12.08 - 18.04
Dividendos
$0.19 (1.29%)
Fecha ex dividendo
Mar 31, 2026

Acerca de Terumo Corporation

Ver perfil →
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through four segments: Cardiac and Vascular Company, Medical Care Solutions Company, Blood and Cell Technologies Company, and Terumo Organ Technologies. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular stent grafts, and others. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The Terumo Organ Technologies segment provides organ preservation devices. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Shibuya, Japan. Medical Devices · Healthcare

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through four segments: Cardiac and Vascular Company, Medical Care Solutions Company, Blood and Cell Technologies Company, and Terumo Organ Technologies. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular stent grafts, and others. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The Terumo Organ Technologies segment provides organ preservation devices. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Shibuya, Japan.

Industria Medical Devices
Sector Healthcare
IPO Fecha Jan 5, 2010
Empleados n/a
Bolsa de Valores OTC Markets OTCPK
Símbolo bursátil TRUMY